Dr. Martens plc (LON:DOCS - Get Free Report) shares traded down 1.7% during trading on Monday . The company traded as low as GBX 53.95 ($0.71) and last traded at GBX 54 ($0.72). 881,366 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 2,469,761 shares. The stock had previously closed at GBX 54.95 ($0.73).
Dr. Martens Trading Up 0.7 %
The business's fifty day moving average is GBX 53.37 and its 200-day moving average is GBX 62.27. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. The firm has a market cap of £541.20 million, a P/E ratio of 7.90, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11.
Dr. Martens Cuts Dividend
The firm also recently announced a dividend, which was paid on Tuesday, April 8th. Investors of record on Thursday, March 6th were given a dividend of GBX 0.85 ($0.01) per share. The ex-dividend date was Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens's payout ratio is 42.53%.
Insiders Place Their Bets
In other news, insider Giles Wilson purchased 32,640 shares of the company's stock in a transaction that occurred on Tuesday, March 25th. The shares were acquired at an average cost of GBX 54 ($0.72) per share, with a total value of £17,625.60 ($23,351.35). Over the last three months, insiders acquired 33,413 shares of company stock worth $1,807,882. 4.36% of the stock is owned by corporate insiders.
Dr. Martens Company Profile
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
See Also
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
